Reprint

CAH Screening

Challenges and Opportunities

Edited by
April 2021
146 pages
  • ISBN978-3-0365-0924-2 (Hardback)
  • ISBN978-3-0365-0925-9 (PDF)

This book is a reprint of the Special Issue CAH Screening—Challenges and Opportunities that was published in

Biology & Life Sciences
Medicine & Pharmacology
Public Health & Healthcare
Summary
The aim of this Special Issue of the International Journal of Neonatal Screening on Newborn Screening for Congenital Adrenal Hyperplasia (CAH) is to describe the current state of CAH newborn screening around the world, with a focus on efforts to find solutions to obstacles and on successful strategies to improve the efficiency of CAH screening. It provides insight into the dilemma of optimal timing for specimen collection, successful strategies to reduce the relatively high screening false positive rate, as well as strategies to address limitations in clinical follow-up and the availability of treatment.
Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
congenital adrenal hyperplasia; 17-hydroxyprogesterone; newborn screening; liquid chromatography tandem mass spectrometry; adrenal hyperplasia; congenital; newborn screening; standardization; congenital adrenal hyperplasia; newborn screening; 17-α hydroxyprogesterone; immunoassay; liquid chromatography tandem mass spectrometry; screening pathway; newborn screening; congenital adrenal hyperplasia; NewSTEPs; congenital adrenal hyperplasia; newborn screening; neonatal screening; congenital adrenal hyperplasia; CAH; 21-hydroxylase deficiency; long-term outcome; newborn screening; congenital adrenal hyperplasia; CAH; neonatal screening; congenital adrenal hyperplasia; CAH; 21-hydroxylase deficiency; CYP21A2; dried blood spots; DBS; positive predictive value; PPV; congenital adrenal hyperplasia; inequity; community development; human rights; child; parents; community; chronic; non-communicable diseases; poverty; n/a